Lei Miao 1, Giovanni Targher 2 3, Christopher D. Byrne 4, Ying-Ying Cao 5 ... read more ↘ 6, Ming-Hua Zheng 5 6 Current status and future trends of the global burden of MASLD. Trends in endocrinology and Metabolism. Volume 35, Issue 8, August 2024, Pages 697-707
Rich N.E.;Oji S.;Mufti A.R.;et al. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018; 16: 198-210 e2
Eslam, M., Sarin, S.K., Wong, V.WS. et al. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatol Int 14, 889–919 (2020). https://doi.org/10.1007/s12072-
Zhou K, Dodge JL, Yuan L, Terrault NA. Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults. Dig Dis Sci. 2022 Jul;67(7):3340-3355. doi: 10.1007/s10620-021-07124-w. Epub 2021 Jun 26. PMID: 34173916
Dalmau-Bueno A.Garcia-Altes A.Mari-Dell'olmo M.et al. Trends in socioeconomic inequalities in cirrhosis mortality in an urban area of Southern Europe: a multilevel approach. J Ep
Diagnosis and Non-Invasive Assessment of MASLD in Type 2 Diabetes and Obesity. Chan WK, Petta S, Noureddin M, Goh GBB, Wong VW. Alimentary Pharmacology & Therapeutics. 2024;59 Suppl 1:S23-S40. doi:10.1111/apt.17866.
Noureddin M, Truong E, Mayo R, Et Al.. Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF). Hepatology. 2024 Jan 1;79(1):135-148. doi: 10.1097/HEP.0000000000000542. Epub 2023 Jul 24. PMID: 37505221; PMCID: PMC10718221.
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
ursier J, Guillaume M, Leroy V, et al. Journal of Hepatology. 2019;71(2):389-396. doi:10.1016/j.jhep.2019.04.020. Diagnostic Accuracy of Non-Invasive Tests for Advanced Fibrosis in Patients With NAFLD: An Individual Patient Data Meta-Analysis. Mózes FE, Lee JA, Selvaraj EA, et al.Gut. 2022;71(5):1006-1019. doi:10.1136/gutjnl-2021-324243.
Machado MV. MASLD treatment-a shift in the paradigm is imminent. Front Med (Lausanne). 2023 Dec 11;10:1316284. doi: 10.3389/fmed.2023.1316284. PMID: 38146424; PMCID: PMC10749497. ↖ read less
